MATTHEW COOK: Open Payments
NPI 1447643598 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 34 payments from 12 companies in 2025. Trend: 2023 $610 · 2024 $662 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $270 |
| Novartis Pharmaceuticals Corporation | 5 | $104 |
| AKEBIA THERAPEUTICS INC | 3 | $62 |
| ANI Pharmaceuticals, Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $27 |
| Ardelyx, Inc. | 1 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $24 |
| Travere Therapeutics, Inc. | 1 | $22 |
| Renalytix AI, Inc. | 1 | $21 |
Products named: KRYSTEXXA, Fabhalta, UPLIZNA, Vafseo, PURIFIED CORTROPHIN GEL, JARDIANCE, TAVNEOS, IBSRELA.
Industry payments across NY — which companies pay providers there.
